That is necessary, since the way a protein in the human body folds identifies if a pharmaceutical will be able to bind to that protein and be reliable. In other words, we have to understand how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (jeff brown prediction). And now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're created to do. This was a development nearly no one saw. However it's going to have extensive ramifications for treating illness. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be lots of investment opportunities in this space, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown 2021 stock predictions). That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be surprised if it pulled back maybe substantially before going greater - toxic tech 5 tech darlings. I have actually been covering bitcoin for a long period of time now. Among the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mostly informing readers. But that's not the huge question anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. Mass, Mutual is a relied on 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. self-driving cars. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These companies raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of great private companies on the edge of hitting the public markets And I've been working on a new way for you to invest even prior to these companies go public.
This opportunity has actually been developing over the last couple of years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the details. Go right here to schedule your area free of charge.
Emma Walsh here, handling editor of the Diary. Regular Journal readers know that tech isn't our typical beat (white house). And when it comes to tech investing, we leave it to the professionals. The good news is, we have numerous such professionals in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing experts we know (self-driving cars). In reality, he had several triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the huge image and anticipate what's simply around the corner.
That consists of things like 5G networks, biotech, synthetic intelligence, and much more. These trends are experiencing rapid development and developing extraordinary chances for investors. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown top biotech stock 2021. However in spite of what many readers may think, this is a trend that's just starting. Despite the fact that the COVID-19 pandemic interfered with supply chains in 2015, a remarkable 250 million 5G-enabled devices were still sold.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (united arab emirates). Losing 2 months of production and sales really impacts the number of 5G gadgets are sold in the fiscal year. When you think about all of that, selling 250 million systems is exceptional. More notably, the hold-ups triggered by the pandemic created a lots of pent-up demand. And that demand is now going to be pushed into 2021. In fact, I anticipate that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown stock market prediction. And that's not my only 5G forecast When I've discussed 5G in the past, I have actually explained its three different stages.
In Phase Two, 5G devices go on sale. 5G phones and other items start to reach customers. And in Phase 3, 5G services start to be provided (first lady). That's when we start to see applications working on 5G networks. Consider things like huge multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage 3 by this summer season. This starts something of a virtuous cycle: The majority of people do not really appreciate the innovation. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open up a suite of extraordinary applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The investment opportunities going forward will be massive. Stepping away from 5G, the next important innovation I visualize in 2021 is CRISPR hereditary editing. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. However it is among the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software.
The program can crash or not function correctly. CRISPR utilizes a similar concept but with our genetic code. "Typos" in our genome can result in illness. CRISPR can remedy these "typos." For many years, CRISPR was mostly a specific niche innovation that wasn't well comprehended. And during that time, there were truly just 3 companies operating in this area. But things are changing. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're dealing with diseases and seeing that this innovation just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering amazing returns. This entire industry is successfully a greenfield opportunity.
There's space for many business to exist in this area. jeff brown 2021 predictions. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that 2 or 3 more genetic modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things occurring at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software can properly forecast the folding of a protein based exclusively on its amino acid sequence with 92. 4% accuracy. That is necessary due to the fact that the method a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been a trial-and-error process. Now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but numerous drug therapies produced utilizing this technology. This was among those breakthroughs that almost no one noticed. But it's going to have profound ramifications for treating illness. And, naturally, there will be plenty of investment chances in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it drew back perhaps significantly prior to going higher. I've been covering bitcoin for a long period of time now. One of the very first research study reports I ever released was on bitcoin - black sea. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my recommendation. However at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
However nobody is asking that concern anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. jeff brown top biotech 2020. Mass, Mutual is a 150-year-old organization. So think about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer prediction In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and declares the information is up to date as of February 2021, however we might not individually verify this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this minute. Brown is best known for his sage-like ability to pick winning innovation stocks. He spent more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an outstanding perspective on the market. He's always on the hunt for new chances, and he shares a number of his finest picks in the Near Future Report.
That's high appreciation, however it's not absurdly reasoned. Brown has an outstanding track record as a stock-picker, and he successfully predicted a few of the most significant economic events of the past 20 years. Although he doesn't appear to release his choices to the public, the service's success is a direct indication of Brown's stock-picking expertise. Nobody on Wall Street gets it best each time, but Jeff Brown's accurate forecasts have actually earned him legions of dedicated fans. That says a lot about his ability. The Near Future Report is released by Brownstone Research study, a popular financial research study publisher. Brownstone Research provides numerous research study services with a wide range of expertises - jeff brown genetic sequencing stock.
The company is also connected with Bonner & Partners, another well-respected research study publisher - first lady. On its site, Brownstone states its objective is to provide retail financiers with professional-grade research study: "For too long, the very best investment research has not been available to private investors. It has been generally scheduled for investment banks, hedge funds, personal equity, and high-net-worth customers. angel investor. The objective of Brownstone Research is to make that kind of proprietary research study available to any investors looking to gain an edge in the marketplaces. The goal is easy to deliver special and rewarding financial investment research discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise serves as the company's Chief Financial investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After decades of stable success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a household name throughout the majority of America. If you know even a bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. what is the legacy report predicting. Everything he touches relies on gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In fact, Brown thinks S.A.V. artificial intelligence. might be "the greatest trend of the 2020s, and he's not alone. Check out these quotes from other well-known S.A.V. bulls: Elon's next big act will be marrying two cutting-edge innovations: expert system and electrical vehicles. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving vehicles ever. It's nothing short of the automobile market's Holy Grail. As you know, electric lorries and self-driving car stocks have actually been big this year, however the Wall Street maker has actually been huge on hype without much tangible outcome. In spite of a drastic boost in competition over the past couple of years, Brown still believes Musk has the best chance of putting everything together.
tech could be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Car, and it might be the future of transportation. Essentially, this technology would permit you to rent your automobile as an autonomous, self-driving taxi when you're not using it. You simply leave the vehicle and press a button on an app that tells the automobile to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a substantial chunk of the revenues. It sounds ridiculous, however it could be closed than you think.